Evolus, Inc. (EOLS) 10-Year Financial Performance & Capital Metrics

EOLS • • Industrial / General

HealthcareSpecialty & Generic PharmaSpecialty PharmaceuticalsDermatology & Aesthetics

AboutEvolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.Show more

Revenue $266M +31.8%
EBITDA -$28M +34.5%
Net Income -$50M +18.3%
EPS (Diluted) -0.81 +25.0%
Gross Margin 68.46% -1.5%
EBITDA Margin -10.66% +50.3%
Operating Margin -12.92% +47.0%
Net Margin -18.94% +38.0%
ROE -913.08%
ROIC -56.37% +37.4%
Debt/Equity 23.54
Interest Coverage -1.84 +48.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 50.1%
✓Efficient asset utilization: 1.1x turnover

✗Weaknesses

✗High debt to equity ratio of 23.5x
✗Negative free cash flow
✗Weak momentum: RS Rating 11 (bottom 11%)
✗Low quality earnings: Net income not backed by cash flow
✗Trading more than 30% below 52-week high
✗Expensive at 56.2x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y50.12%

3Y38.76%

TTM15.1%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-5.59%

EPS CAGR

10Y-

5Y-

3Y-

TTM-1.1%

ROCE

10Y Avg-58.73%

5Y Avg-52.34%

3Y Avg-32.6%

Latest-22.18%

Peer Comparison

Dermatology & Aesthetics

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
BFRIBiofrontera Inc.	9.73M	0.84	-0.26	9.49%	-47.28%	-384.98%	1.11
EOLSEvolus, Inc.	324.1M	5.00	-6.17	31.76%	-20.49%	-9.13%	23.54
DERMJourney Medical Corporation	176.7M	8.36	-11.61	-29.11%	-15.49%	-45.4%	1.28

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	0	0	34.92M	56.54M	99.67M	148.62M	202.09M	266.27M
Revenue Growth %	-	-	-	-	-	0.62%	0.76%	0.49%	0.36%	0.32%
Cost of Goods Sold+	416K	326K	218K	9K	8.01M	18.3M	43.53M	58.84M	61.56M	83.97M
COGS % of Revenue	-	-	-	-	0.23%	0.32%	0.44%	0.4%	0.3%	0.32%
Gross Profit+	-416K	-326K	-218K	-9K	26.91M	38.24M	56.14M	89.77M	140.53M	182.3M
Gross Margin %	-	-	-	-	0.77%	0.68%	0.56%	0.6%	0.7%	0.68%
Gross Profit Growth %	-	0.22%	0.33%	0.96%	2991.11%	0.42%	0.47%	0.6%	0.57%	0.3%
Operating Expenses+	30.98M	19.97M	11.73M	35.64M	125.86M	191.31M	100.54M	155.1M	189.76M	216.72M
OpEx % of Revenue	-	-	-	-	3.6%	3.38%	1.01%	1.04%	0.94%	0.81%
Selling, General & Admin	9.88M	7.03M	4.82M	29.15M	113.59M	98.19M	112.07M	141.84M	164.94M	198.03M
SG&A % of Revenue	-	-	-	-	3.25%	1.74%	1.12%	0.95%	0.82%	0.74%
Research & Development	20.68M	12.61M	6.69M	6.49M	3.97M	1.72M	2.06M	6.74M	15.43M	9.17M
R&D % of Revenue	-	-	-	-	0.11%	0.03%	0.02%	0.05%	0.08%	0.03%
Other Operating Expenses	-39K	-6K	-5K	0	8.29M	91.4M	-13.59M	6.52M	9.39M	9.52M
Operating Income+	-30.98M	-19.97M	-11.73M	-46.14M	-98.95M	-153.07M	-44.41M	-65.33M	-49.23M	-34.41M
Operating Margin %	-	-	-	-	-2.83%	-2.71%	-0.45%	-0.44%	-0.24%	-0.13%
Operating Income Growth %	-	0.36%	0.41%	-2.94%	-1.14%	-0.55%	0.71%	-0.47%	0.25%	0.3%
EBITDA+	-30.56M	-19.64M	-11.51M	-46.13M	-93.94M	-145.39M	-38.09M	-61.61M	-43.37M	-28.39M
EBITDA Margin %	-	-	-	-	-2.69%	-2.57%	-0.38%	-0.41%	-0.21%	-0.11%
EBITDA Growth %	-	0.36%	0.41%	-3.01%	-1.04%	-0.55%	0.74%	-0.62%	0.3%	0.35%
D&A (Non-Cash Add-back)	416K	326K	218K	9K	5M	7.68M	6.31M	3.72M	5.87M	6.02M
EBIT	-30.98M	-19.97M	-11.73M	-45.94M	-97.11M	-152.43M	-45.37M	-57.58M	-47.68M	-31.02M
Net Interest Income+	0	0	0	-660K	-6.11M	-9.87M	-1.4M	-8.98M	-12.97M	-15.47M
Interest Income	0	0	0	203K	1.84M	635K	1K	119K	860K	3.26M
Interest Expense	0	0	0	863K	7.95M	10.5M	1.4M	9.1M	13.83M	18.73M
Other Income/Expense	-39K	-6K	-5K	-660K	-6.11M	-9.87M	-2.36M	-8.99M	-12.28M	-15.35M
Pretax Income+	-31.02M	-19.97M	-11.73M	-46.8M	-105.06M	-162.94M	-46.77M	-74.32M	-61.51M	-49.76M
Pretax Margin %	-	-	-	-	-3.01%	-2.88%	-0.47%	-0.5%	-0.3%	-0.19%
Income Tax+	93K	93K	-7.25M	65K	-15.03M	77K	42K	95K	176K	664K
Effective Tax Rate %	1%	1%	0.38%	1%	0.86%	1%	1%	1%	1%	1.01%
Net Income+	-31.11M	-20.07M	-4.48M	-46.87M	-90.03M	-163.01M	-46.81M	-74.41M	-61.69M	-50.42M
Net Margin %	-	-	-	-	-2.58%	-2.88%	-0.47%	-0.5%	-0.31%	-0.19%
Net Income Growth %	-	0.36%	0.78%	-9.46%	-0.92%	-0.81%	0.71%	-0.59%	0.17%	0.18%
Net Income (Continuing)	-31.11M	-20.07M	-4.48M	-46.87M	-90.03M	-163.01M	-46.81M	-74.41M	-61.69M	-50.42M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-1.67	-1.08	-0.19	-1.92	-3.19	-4.83	-0.94	-1.33	-1.08	-0.81
EPS Growth %	-	0.35%	0.82%	-9.11%	-0.66%	-0.51%	0.81%	-0.41%	0.19%	0.25%
EPS (Basic)	-1.67	-1.08	-0.19	-1.92	-3.19	-4.83	-0.94	-1.33	-1.08	-0.81
Diluted Shares Outstanding	18.59M	18.59M	23.59M	24.4M	28.24M	33.74M	49.77M	56.07M	56.92M	62.02M
Basic Shares Outstanding	18.59M	18.59M	23.59M	24.4M	28.24M	33.74M	49.77M	56.07M	56.92M	62.02M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	4.02M	211K	72.82M	94.34M	152.2M	127.61M	178.8M	100.8M	112.42M	151.34M
Cash & Short-Term Investments	4M	0	0	93.16M	129.8M	107.56M	146.26M	53.92M	62.84M	86.95M
Cash Only	4M	0	0	93.16M	109.89M	102.56M	146.26M	53.92M	62.84M	86.95M
Short-Term Investments	0	0	0	0	19.91M	5M	0	0	0	0
Accounts Receivable	0	0	72.64M	0	10.66M	9.68M	14.66M	22.45M	30.53M	47.68M
Days Sales Outstanding	-	-	-	-	111.42	62.49	53.67	55.13	55.14	65.36
Inventory	0	0	0	0	6.41M	3.35M	1.76M	18.85M	11M	12.16M
Days Inventory Outstanding	-	-	-	-	291.81	66.9	14.77	116.94	65.21	52.85
Other Current Assets	4M	187K	0	1.18M	0	2.19M	11.04M	1.68M	2.36M	1.2M
Total Non-Current Assets+	77.28M	77.28M	79.41M	77.5M	88.25M	81.46M	78.68M	77.18M	76.58M	81.23M
Property, Plant & Equipment	0	0	0	0	4.97M	4.71M	4.09M	4.56M	7.85M	10.41M
Fixed Asset Turnover	-	-	-	-	7.03x	12.00x	24.35x	32.57x	25.74x	25.59x
Goodwill	21.21M	21.21M	21.21M	21.21M	21.21M	21.21M	21.21M	21.21M	21.21M	21.21M
Intangible Assets	56.08M	56.08M	56.08M	56.08M	59.64M	55.3M	50.63M	48.6M	47.11M	48.75M
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	2.13M	221K	2.43M	240K	2.76M	2.81M	409K	858K
Total Assets+	81.3M	77.5M	152.23M	171.84M	240.44M	209.07M	257.48M	177.98M	189M	232.57M
Asset Turnover	-	-	-	-	0.15x	0.27x	0.39x	0.84x	1.07x	1.14x
Asset Growth %	-	-0.05%	0.96%	0.13%	0.4%	-0.13%	0.23%	-0.31%	0.06%	0.23%
Total Current Liabilities+	48.1M	63.31M	212.75M	5.28M	24.44M	180.25M	57.66M	46.51M	48.29M	62.96M
Accounts Payable	230K	2.88M	445K	1.56M	5.8M	9.62M	6.09M	8.94M	4.27M	9.24M
Days Payables Outstanding	201.8	3.22K	745.07	63.19K	263.98	191.79	51.07	55.42	25.32	40.15
Short-Term Debt	46.17M	59.76M	211.33M	0	0	93.45M	0	0	0	0
Deferred Revenue (Current)	0	0	0	0	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	0	0	0	1.14M	0	0	0	0	18.18M	0
Current Ratio	0.08x	0.00x	0.34x	17.88x	6.23x	0.71x	3.10x	2.17x	2.33x	2.40x
Quick Ratio	0.08x	0.00x	0.34x	17.88x	5.97x	0.69x	3.07x	1.76x	2.10x	2.21x
Cash Conversion Cycle	-	-	-	-	139.25	-62.39	17.38	116.65	95.03	78.06
Total Non-Current Liabilities+	21.2M	21.29M	15.03M	82.18M	136.55M	101.78M	117.94M	112.97M	161.4M	164.09M
Long-Term Debt	0	0	0	16.9M	91.45M	40.51M	71.22M	71.88M	120.36M	121.51M
Capital Lease Obligations	0	0	0	0	3.89M	3.15M	2.26M	1.22M	4.81M	6.75M
Deferred Tax Liabilities	21.15M	21.25M	14.99M	15.05M	0	25K	40K	22K	27K	6K
Other Non-Current Liabilities	46K	44K	38K	50.23M	41.2M	58.1M	44.43M	39.85M	36.2M	35.82M
Total Liabilities	69.3M	84.6M	227.78M	87.46M	160.99M	282.03M	175.61M	159.48M	209.69M	227.05M
Total Debt+	46.17M	59.76M	211.33M	16.9M	96.55M	138.32M	74.74M	74.42M	126.55M	129.98M
Net Debt	42.17M	59.76M	211.33M	-76.26M	-13.35M	35.76M	-71.51M	20.5M	63.71M	43.03M
Debt / Equity	3.85x	-	-	-	1.22x	-	0.91x	4.02x	-	23.54x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-	-	-	-53.47x	-12.44x	-14.57x	-31.81x	-7.18x	-3.56x	-1.84x
Total Equity+	12M	-7.11M	-75.54M	-123.03M	79.46M	-72.96M	81.88M	18.5M	-20.69M	5.52M
Equity Growth %	-	-1.59%	-9.63%	-0.63%	1.65%	-1.92%	2.12%	-0.77%	-2.12%	1.27%
Book Value per Share	0.65	-0.38	-3.20	-5.04	2.81	-2.16	1.64	0.33	-0.36	0.09
Total Shareholders' Equity	12M	-7.11M	-75.54M	-123.03M	79.46M	-72.96M	81.88M	18.5M	-20.69M	5.52M
Common Stock	0	0	0	1K	1K	1K	1K	1K	1K	1K
Retained Earnings	-46.74M	-66.81M	-75.54M	-123.03M	-213.06M	-376.07M	-422.88M	-497.29M	-558.98M	-609.4M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	6K	0	0	-337K	-427K	-905K
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-36.38M	-13.27M	-13.04M	-25.67M	-93.38M	-57.87M	-33.39M	-84.91M	-34.01M	-18M
Operating CF Margin %	-	-	-	-	-2.67%	-1.02%	-0.33%	-0.57%	-0.17%	-0.07%
Operating CF Growth %	-	0.64%	0.02%	-0.97%	-2.64%	0.38%	0.42%	-1.54%	0.6%	0.47%
Net Income	-31.11M	-20.07M	-4.48M	-46.87M	-90.03M	-163.01M	-46.81M	-74.41M	-61.69M	-50.42M
Depreciation & Amortization	416K	326K	218K	9K	5M	7.68M	6.31M	4.5M	5.87M	6.02M
Stock-Based Compensation	1.51M	957K	586K	6.97M	9.52M	10.58M	9.58M	10.83M	16.46M	22.25M
Deferred Taxes	93K	93K	-7.25M	65K	-15.05M	25K	15K	-18K	5K	-21K
Other Non-Cash Items	3.72M	-1.04M	2.46M	11.36M	17.99M	51.25M	9.06M	8.44M	11.24M	10.77M
Working Capital Changes	-7.29M	5.42M	-2.11M	2.79M	-20.81M	35.6M	-11.54M	-34.25M	-5.89M	-6.6M
Change in Receivables	0	0	0	0	-11.05M	-1.08M	-5.57M	-9.39M	-9.52M	-19.6M
Change in Inventory	0	0	0	0	-4.48M	4.54M	-2.98M	-10.69M	4.19M	3.25M
Change in Payables	-1.37M	2.65M	-2.43M	1.27M	183K	2.32M	-787K	968K	-1.02M	391K
Cash from Investing+	0	0	0	-9K	-23.43M	12.19M	4.03M	-2.94M	-1.63M	-4.82M
Capital Expenditures	0	0	0	-9K	-4.57M	-3.14M	-393K	-1.62M	-473K	-1.47M
CapEx % of Revenue	-	-	-	-	0.13%	0.06%	0%	0.01%	0%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	-4.22M	-2.32M	-577K	-1.32M	-1.15M	-3.35M
Cash from Financing+	36.38M	13.27M	13.04M	118.84M	133.55M	38.35M	73.05M	-4.15M	44.64M	47.41M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	0	-1.29M	119.08M	-12.63M	-1.13M	-5.92M	-4.15M	-5.36M	-3.8M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-36.38M	-13.27M	-13.04M	-25.68M	-97.95M	-61.01M	-34.36M	-87.85M	-35.63M	-19.47M
FCF Margin %	-	-	-	-	-2.8%	-1.08%	-0.34%	-0.59%	-0.18%	-0.07%
FCF Growth %	-	0.64%	0.02%	-0.97%	-2.81%	0.38%	0.44%	-1.56%	0.59%	0.45%
FCF per Share	-1.96	-0.71	-0.55	-1.05	-3.47	-1.81	-0.69	-1.57	-0.63	-0.31
FCF Conversion (FCF/Net Income)	1.17x	0.66x	2.91x	0.55x	1.04x	0.36x	0.71x	1.14x	0.55x	0.36x
Interest Paid	0	0	0	0	5.17M	7.24M	138K	8M	12.71M	17.55M
Taxes Paid	0	0	0	0	4K	65K	14K	76K	117K	235K

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-259.22%	-819.65%	-	-	-113.31%	-5016.56%	-1049.79%	-148.27%	-	-913.08%
Return on Invested Capital (ROIC)	-42.89%	-28.04%	-9.33%	-	-112.25%	-794.25%	-321.37%	-198.52%	-90.04%	-56.37%
Gross Margin	-	-	-	-	77.05%	67.64%	56.32%	60.41%	69.54%	68.46%
Net Margin	-	-	-	-	-257.79%	-288.31%	-46.96%	-50.07%	-30.52%	-18.94%
Debt / Equity	3.85x	-	-	-	1.22x	-	0.91x	4.02x	-	23.54x
Interest Coverage	-	-	-	-53.47x	-12.44x	-14.57x	-31.81x	-7.18x	-3.56x	-1.84x
FCF Conversion	1.17x	0.66x	2.91x	0.55x	1.04x	0.36x	0.71x	1.14x	0.55x	0.36x
Revenue Growth	-	-	-	-	-	61.89%	76.29%	49.1%	35.98%	31.76%

Revenue by Segment

	2019	2020	2021	2022	2023	2024
Product	34.24M	55.8M	98.97M	146.59M	199.72M	264.31M
Product Growth	-	62.99%	77.36%	48.12%	36.24%	32.34%
Service	-	-	-	2.02M	2.36M	1.97M
Service Growth	-	-	-	-	16.80%	-16.75%

Revenue by Geography

	2019	2020	2021	2022	2023	2024
UNITED STATES	-	-	-	-	-	253.16M
UNITED STATES Growth	-	-	-	-	-	-
Non-US	-	-	-	-	-	13.12M
Non-US Growth	-	-	-	-	-	-
CANADA	-	738K	702K	-	-	-
CANADA Growth	-	-	-4.88%	-	-	-

Frequently Asked Questions

Growth & Financials

Evolus, Inc. (EOLS) reported $285.8M in revenue for fiscal year 2024.

Evolus, Inc. (EOLS) grew revenue by 31.8% over the past year. This is strong growth.

Evolus, Inc. (EOLS) reported a net loss of $58.6M for fiscal year 2024.

Dividend & Returns

Evolus, Inc. (EOLS) has a return on equity (ROE) of -913.1%. Negative ROE indicates the company is unprofitable.

Evolus, Inc. (EOLS) had negative free cash flow of $56.4M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Evolus, Inc. (EOLS) 10-Year Financial Performance & Capital Metrics

EOLS • • Industrial / General

HealthcareSpecialty & Generic PharmaSpecialty PharmaceuticalsDermatology & Aesthetics

Revenue $266M +31.8%
EBITDA -$28M +34.5%
Net Income -$50M +18.3%
EPS (Diluted) -0.81 +25.0%
Gross Margin 68.46% -1.5%
EBITDA Margin -10.66% +50.3%
Operating Margin -12.92% +47.0%
Net Margin -18.94% +38.0%
ROE -913.08%
ROIC -56.37% +37.4%
Debt/Equity 23.54
Interest Coverage -1.84 +48.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 50.1%
✓Efficient asset utilization: 1.1x turnover

✗Weaknesses

✗High debt to equity ratio of 23.5x
✗Negative free cash flow
✗Weak momentum: RS Rating 11 (bottom 11%)
✗Low quality earnings: Net income not backed by cash flow
✗Trading more than 30% below 52-week high
✗Expensive at 56.2x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y50.12%

3Y38.76%

TTM15.1%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-5.59%

EPS CAGR

10Y-

5Y-

3Y-

TTM-1.1%

ROCE

10Y Avg-58.73%

5Y Avg-52.34%

3Y Avg-32.6%

Latest-22.18%

Peer Comparison

Dermatology & Aesthetics

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
BFRIBiofrontera Inc.	9.73M	0.84	-0.26	9.49%	-47.28%	-384.98%	1.11
EOLSEvolus, Inc.	324.1M	5.00	-6.17	31.76%	-20.49%	-9.13%	23.54
DERMJourney Medical Corporation	176.7M	8.36	-11.61	-29.11%	-15.49%	-45.4%	1.28

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	0	0	34.92M	56.54M	99.67M	148.62M	202.09M	266.27M
Revenue Growth %	-	-	-	-	-	0.62%	0.76%	0.49%	0.36%	0.32%
Cost of Goods Sold+	416K	326K	218K	9K	8.01M	18.3M	43.53M	58.84M	61.56M	83.97M
COGS % of Revenue	-	-	-	-	0.23%	0.32%	0.44%	0.4%	0.3%	0.32%
Gross Profit+	-416K	-326K	-218K	-9K	26.91M	38.24M	56.14M	89.77M	140.53M	182.3M
Gross Margin %	-	-	-	-	0.77%	0.68%	0.56%	0.6%	0.7%	0.68%
Gross Profit Growth %	-	0.22%	0.33%	0.96%	2991.11%	0.42%	0.47%	0.6%	0.57%	0.3%
Operating Expenses+	30.98M	19.97M	11.73M	35.64M	125.86M	191.31M	100.54M	155.1M	189.76M	216.72M
OpEx % of Revenue	-	-	-	-	3.6%	3.38%	1.01%	1.04%	0.94%	0.81%
Selling, General & Admin	9.88M	7.03M	4.82M	29.15M	113.59M	98.19M	112.07M	141.84M	164.94M	198.03M
SG&A % of Revenue	-	-	-	-	3.25%	1.74%	1.12%	0.95%	0.82%	0.74%
Research & Development	20.68M	12.61M	6.69M	6.49M	3.97M	1.72M	2.06M	6.74M	15.43M	9.17M
R&D % of Revenue	-	-	-	-	0.11%	0.03%	0.02%	0.05%	0.08%	0.03%
Other Operating Expenses	-39K	-6K	-5K	0	8.29M	91.4M	-13.59M	6.52M	9.39M	9.52M
Operating Income+	-30.98M	-19.97M	-11.73M	-46.14M	-98.95M	-153.07M	-44.41M	-65.33M	-49.23M	-34.41M
Operating Margin %	-	-	-	-	-2.83%	-2.71%	-0.45%	-0.44%	-0.24%	-0.13%
Operating Income Growth %	-	0.36%	0.41%	-2.94%	-1.14%	-0.55%	0.71%	-0.47%	0.25%	0.3%
EBITDA+	-30.56M	-19.64M	-11.51M	-46.13M	-93.94M	-145.39M	-38.09M	-61.61M	-43.37M	-28.39M
EBITDA Margin %	-	-	-	-	-2.69%	-2.57%	-0.38%	-0.41%	-0.21%	-0.11%
EBITDA Growth %	-	0.36%	0.41%	-3.01%	-1.04%	-0.55%	0.74%	-0.62%	0.3%	0.35%
D&A (Non-Cash Add-back)	416K	326K	218K	9K	5M	7.68M	6.31M	3.72M	5.87M	6.02M
EBIT	-30.98M	-19.97M	-11.73M	-45.94M	-97.11M	-152.43M	-45.37M	-57.58M	-47.68M	-31.02M
Net Interest Income+	0	0	0	-660K	-6.11M	-9.87M	-1.4M	-8.98M	-12.97M	-15.47M
Interest Income	0	0	0	203K	1.84M	635K	1K	119K	860K	3.26M
Interest Expense	0	0	0	863K	7.95M	10.5M	1.4M	9.1M	13.83M	18.73M
Other Income/Expense	-39K	-6K	-5K	-660K	-6.11M	-9.87M	-2.36M	-8.99M	-12.28M	-15.35M
Pretax Income+	-31.02M	-19.97M	-11.73M	-46.8M	-105.06M	-162.94M	-46.77M	-74.32M	-61.51M	-49.76M
Pretax Margin %	-	-	-	-	-3.01%	-2.88%	-0.47%	-0.5%	-0.3%	-0.19%
Income Tax+	93K	93K	-7.25M	65K	-15.03M	77K	42K	95K	176K	664K
Effective Tax Rate %	1%	1%	0.38%	1%	0.86%	1%	1%	1%	1%	1.01%
Net Income+	-31.11M	-20.07M	-4.48M	-46.87M	-90.03M	-163.01M	-46.81M	-74.41M	-61.69M	-50.42M
Net Margin %	-	-	-	-	-2.58%	-2.88%	-0.47%	-0.5%	-0.31%	-0.19%
Net Income Growth %	-	0.36%	0.78%	-9.46%	-0.92%	-0.81%	0.71%	-0.59%	0.17%	0.18%
Net Income (Continuing)	-31.11M	-20.07M	-4.48M	-46.87M	-90.03M	-163.01M	-46.81M	-74.41M	-61.69M	-50.42M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-1.67	-1.08	-0.19	-1.92	-3.19	-4.83	-0.94	-1.33	-1.08	-0.81
EPS Growth %	-	0.35%	0.82%	-9.11%	-0.66%	-0.51%	0.81%	-0.41%	0.19%	0.25%
EPS (Basic)	-1.67	-1.08	-0.19	-1.92	-3.19	-4.83	-0.94	-1.33	-1.08	-0.81
Diluted Shares Outstanding	18.59M	18.59M	23.59M	24.4M	28.24M	33.74M	49.77M	56.07M	56.92M	62.02M
Basic Shares Outstanding	18.59M	18.59M	23.59M	24.4M	28.24M	33.74M	49.77M	56.07M	56.92M	62.02M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	4.02M	211K	72.82M	94.34M	152.2M	127.61M	178.8M	100.8M	112.42M	151.34M
Cash & Short-Term Investments	4M	0	0	93.16M	129.8M	107.56M	146.26M	53.92M	62.84M	86.95M
Cash Only	4M	0	0	93.16M	109.89M	102.56M	146.26M	53.92M	62.84M	86.95M
Short-Term Investments	0	0	0	0	19.91M	5M	0	0	0	0
Accounts Receivable	0	0	72.64M	0	10.66M	9.68M	14.66M	22.45M	30.53M	47.68M
Days Sales Outstanding	-	-	-	-	111.42	62.49	53.67	55.13	55.14	65.36
Inventory	0	0	0	0	6.41M	3.35M	1.76M	18.85M	11M	12.16M
Days Inventory Outstanding	-	-	-	-	291.81	66.9	14.77	116.94	65.21	52.85
Other Current Assets	4M	187K	0	1.18M	0	2.19M	11.04M	1.68M	2.36M	1.2M
Total Non-Current Assets+	77.28M	77.28M	79.41M	77.5M	88.25M	81.46M	78.68M	77.18M	76.58M	81.23M
Property, Plant & Equipment	0	0	0	0	4.97M	4.71M	4.09M	4.56M	7.85M	10.41M
Fixed Asset Turnover	-	-	-	-	7.03x	12.00x	24.35x	32.57x	25.74x	25.59x
Goodwill	21.21M	21.21M	21.21M	21.21M	21.21M	21.21M	21.21M	21.21M	21.21M	21.21M
Intangible Assets	56.08M	56.08M	56.08M	56.08M	59.64M	55.3M	50.63M	48.6M	47.11M	48.75M
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	2.13M	221K	2.43M	240K	2.76M	2.81M	409K	858K
Total Assets+	81.3M	77.5M	152.23M	171.84M	240.44M	209.07M	257.48M	177.98M	189M	232.57M
Asset Turnover	-	-	-	-	0.15x	0.27x	0.39x	0.84x	1.07x	1.14x
Asset Growth %	-	-0.05%	0.96%	0.13%	0.4%	-0.13%	0.23%	-0.31%	0.06%	0.23%
Total Current Liabilities+	48.1M	63.31M	212.75M	5.28M	24.44M	180.25M	57.66M	46.51M	48.29M	62.96M
Accounts Payable	230K	2.88M	445K	1.56M	5.8M	9.62M	6.09M	8.94M	4.27M	9.24M
Days Payables Outstanding	201.8	3.22K	745.07	63.19K	263.98	191.79	51.07	55.42	25.32	40.15
Short-Term Debt	46.17M	59.76M	211.33M	0	0	93.45M	0	0	0	0
Deferred Revenue (Current)	0	0	0	0	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	0	0	0	1.14M	0	0	0	0	18.18M	0
Current Ratio	0.08x	0.00x	0.34x	17.88x	6.23x	0.71x	3.10x	2.17x	2.33x	2.40x
Quick Ratio	0.08x	0.00x	0.34x	17.88x	5.97x	0.69x	3.07x	1.76x	2.10x	2.21x
Cash Conversion Cycle	-	-	-	-	139.25	-62.39	17.38	116.65	95.03	78.06
Total Non-Current Liabilities+	21.2M	21.29M	15.03M	82.18M	136.55M	101.78M	117.94M	112.97M	161.4M	164.09M
Long-Term Debt	0	0	0	16.9M	91.45M	40.51M	71.22M	71.88M	120.36M	121.51M
Capital Lease Obligations	0	0	0	0	3.89M	3.15M	2.26M	1.22M	4.81M	6.75M
Deferred Tax Liabilities	21.15M	21.25M	14.99M	15.05M	0	25K	40K	22K	27K	6K
Other Non-Current Liabilities	46K	44K	38K	50.23M	41.2M	58.1M	44.43M	39.85M	36.2M	35.82M
Total Liabilities	69.3M	84.6M	227.78M	87.46M	160.99M	282.03M	175.61M	159.48M	209.69M	227.05M
Total Debt+	46.17M	59.76M	211.33M	16.9M	96.55M	138.32M	74.74M	74.42M	126.55M	129.98M
Net Debt	42.17M	59.76M	211.33M	-76.26M	-13.35M	35.76M	-71.51M	20.5M	63.71M	43.03M
Debt / Equity	3.85x	-	-	-	1.22x	-	0.91x	4.02x	-	23.54x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-	-	-	-53.47x	-12.44x	-14.57x	-31.81x	-7.18x	-3.56x	-1.84x
Total Equity+	12M	-7.11M	-75.54M	-123.03M	79.46M	-72.96M	81.88M	18.5M	-20.69M	5.52M
Equity Growth %	-	-1.59%	-9.63%	-0.63%	1.65%	-1.92%	2.12%	-0.77%	-2.12%	1.27%
Book Value per Share	0.65	-0.38	-3.20	-5.04	2.81	-2.16	1.64	0.33	-0.36	0.09
Total Shareholders' Equity	12M	-7.11M	-75.54M	-123.03M	79.46M	-72.96M	81.88M	18.5M	-20.69M	5.52M
Common Stock	0	0	0	1K	1K	1K	1K	1K	1K	1K
Retained Earnings	-46.74M	-66.81M	-75.54M	-123.03M	-213.06M	-376.07M	-422.88M	-497.29M	-558.98M	-609.4M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	6K	0	0	-337K	-427K	-905K
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-36.38M	-13.27M	-13.04M	-25.67M	-93.38M	-57.87M	-33.39M	-84.91M	-34.01M	-18M
Operating CF Margin %	-	-	-	-	-2.67%	-1.02%	-0.33%	-0.57%	-0.17%	-0.07%
Operating CF Growth %	-	0.64%	0.02%	-0.97%	-2.64%	0.38%	0.42%	-1.54%	0.6%	0.47%
Net Income	-31.11M	-20.07M	-4.48M	-46.87M	-90.03M	-163.01M	-46.81M	-74.41M	-61.69M	-50.42M
Depreciation & Amortization	416K	326K	218K	9K	5M	7.68M	6.31M	4.5M	5.87M	6.02M
Stock-Based Compensation	1.51M	957K	586K	6.97M	9.52M	10.58M	9.58M	10.83M	16.46M	22.25M
Deferred Taxes	93K	93K	-7.25M	65K	-15.05M	25K	15K	-18K	5K	-21K
Other Non-Cash Items	3.72M	-1.04M	2.46M	11.36M	17.99M	51.25M	9.06M	8.44M	11.24M	10.77M
Working Capital Changes	-7.29M	5.42M	-2.11M	2.79M	-20.81M	35.6M	-11.54M	-34.25M	-5.89M	-6.6M
Change in Receivables	0	0	0	0	-11.05M	-1.08M	-5.57M	-9.39M	-9.52M	-19.6M
Change in Inventory	0	0	0	0	-4.48M	4.54M	-2.98M	-10.69M	4.19M	3.25M
Change in Payables	-1.37M	2.65M	-2.43M	1.27M	183K	2.32M	-787K	968K	-1.02M	391K
Cash from Investing+	0	0	0	-9K	-23.43M	12.19M	4.03M	-2.94M	-1.63M	-4.82M
Capital Expenditures	0	0	0	-9K	-4.57M	-3.14M	-393K	-1.62M	-473K	-1.47M
CapEx % of Revenue	-	-	-	-	0.13%	0.06%	0%	0.01%	0%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	-4.22M	-2.32M	-577K	-1.32M	-1.15M	-3.35M
Cash from Financing+	36.38M	13.27M	13.04M	118.84M	133.55M	38.35M	73.05M	-4.15M	44.64M	47.41M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	0	-1.29M	119.08M	-12.63M	-1.13M	-5.92M	-4.15M	-5.36M	-3.8M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-36.38M	-13.27M	-13.04M	-25.68M	-97.95M	-61.01M	-34.36M	-87.85M	-35.63M	-19.47M
FCF Margin %	-	-	-	-	-2.8%	-1.08%	-0.34%	-0.59%	-0.18%	-0.07%
FCF Growth %	-	0.64%	0.02%	-0.97%	-2.81%	0.38%	0.44%	-1.56%	0.59%	0.45%
FCF per Share	-1.96	-0.71	-0.55	-1.05	-3.47	-1.81	-0.69	-1.57	-0.63	-0.31
FCF Conversion (FCF/Net Income)	1.17x	0.66x	2.91x	0.55x	1.04x	0.36x	0.71x	1.14x	0.55x	0.36x
Interest Paid	0	0	0	0	5.17M	7.24M	138K	8M	12.71M	17.55M
Taxes Paid	0	0	0	0	4K	65K	14K	76K	117K	235K

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-259.22%	-819.65%	-	-	-113.31%	-5016.56%	-1049.79%	-148.27%	-	-913.08%
Return on Invested Capital (ROIC)	-42.89%	-28.04%	-9.33%	-	-112.25%	-794.25%	-321.37%	-198.52%	-90.04%	-56.37%
Gross Margin	-	-	-	-	77.05%	67.64%	56.32%	60.41%	69.54%	68.46%
Net Margin	-	-	-	-	-257.79%	-288.31%	-46.96%	-50.07%	-30.52%	-18.94%
Debt / Equity	3.85x	-	-	-	1.22x	-	0.91x	4.02x	-	23.54x
Interest Coverage	-	-	-	-53.47x	-12.44x	-14.57x	-31.81x	-7.18x	-3.56x	-1.84x
FCF Conversion	1.17x	0.66x	2.91x	0.55x	1.04x	0.36x	0.71x	1.14x	0.55x	0.36x
Revenue Growth	-	-	-	-	-	61.89%	76.29%	49.1%	35.98%	31.76%

Revenue by Segment

	2019	2020	2021	2022	2023	2024
Product	34.24M	55.8M	98.97M	146.59M	199.72M	264.31M
Product Growth	-	62.99%	77.36%	48.12%	36.24%	32.34%
Service	-	-	-	2.02M	2.36M	1.97M
Service Growth	-	-	-	-	16.80%	-16.75%

Revenue by Geography

	2019	2020	2021	2022	2023	2024
UNITED STATES	-	-	-	-	-	253.16M
UNITED STATES Growth	-	-	-	-	-	-
Non-US	-	-	-	-	-	13.12M
Non-US Growth	-	-	-	-	-	-
CANADA	-	738K	702K	-	-	-
CANADA Growth	-	-	-4.88%	-	-	-

Frequently Asked Questions

Growth & Financials

Evolus, Inc. (EOLS) reported $285.8M in revenue for fiscal year 2024.

Evolus, Inc. (EOLS) grew revenue by 31.8% over the past year. This is strong growth.

Evolus, Inc. (EOLS) reported a net loss of $58.6M for fiscal year 2024.

Dividend & Returns

Evolus, Inc. (EOLS) has a return on equity (ROE) of -913.1%. Negative ROE indicates the company is unprofitable.

Evolus, Inc. (EOLS) had negative free cash flow of $56.4M in fiscal year 2024, likely due to heavy capital investments.